Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trial - The Lancet
[unable to retrieve full-text content] Emerging biomarkers and frontier therapies: unveiling the role of endothelial dysfunction in cerebral small vessel disease Frontiers
[unable to retrieve full-text content] Progress on Cardiovascular Disease Care in the U.S. Has Stalled Despite Treatment Advances, New Report Finds The Harvard Crimson
Comments
Post a Comment